DES | Optima Jet

Technical Data | Ordering Information

Unique device Technology

Proprietary Abluminal Reservoir Technology

  • Slow, controlled and complete (100%) elution of the drug
  • Targeted drug release only towards the vessel wall
  • Drug protected during stent delivery without additional profile to the stent strut

Polymer-Free drug release

  • Lack of inflammatory/thrombogenic components, thus eliminating the shortcomings often associated with polymers
  • No drug or polymer in contact with the bloodstream
  • The bio & haemo-compatible1 CarbofilmTM coating is the only surface in contact with the blood and vessel wall

A further step ahead in stent delivery system performance

  • Friction-free hydrophilic coating2 for a gold-standard performance in deliverability
  • Extremely short balloon tapers for improved stent strut apposition

Years of experience

CarbofilmTM: for over 30 years, Pyrolytic carbon (same chemical structure of CarbofilmTM) is the only coating used in mechanical heart valves Tacrolimus: a worldwide drug of reference in organ transplants3
  • Stents coated with CarbofilmTM have shown fast endothelialization5 and unbeatable safety results1
(Endothlialization of CarbostentTM DES
located over the ostium of a side branch5)
  • Tacrolimus has shown a selective action in reducing the proliferation of smooth muscle cells rather than endothelial cells4

Clinical evidences
  • 0% thrombosis rate6 at 24 months in randomized trial with all patients’ DAT ≤ 6 months
  • Matrix registry7 at 1 year highlights CarbostentTM DES safety and efficacy with 2 months of DAT regimen duration
  • The results obtained from CarbostendtTM DES allow physicians to treat AF (Atrial Fibrillation) patients, that should benefit from DES efficacy, without increasing the risk of bleeding8
  • Optima CarbostentTM is the only DES to allow 2 months DAT9

1 Hurricane (Antoniucci et al; Cathet Cardiovasc Intervent 2001;54:420-426), Antares (Bartorelli et al; Cathet Cardiovasc Intervent 2002;55:150-156) and Safe (Bartorelli et al; Am J of Cardiol April 2007) studies
2 ComfortCoatTM manufactured by DSM Biomedical
3 Prograf® - Immunosuppressant used to prevent rejection in organ transplants

4 C. Matter, T. Luscher - J Cardiovasc Pharmacol. 2006 Dec;48(6):286-92
5 Dr. Perez De Prado; Journal of Interventional Cardiology, June 2009
6 Prospective randomized clinical trail results at 24 months
7 MATRIX analysis presented during GISE09
8 ESC Guide lines - Thromb Haemost. 2010 Jan;103(1):13-28
9 Product IFU

It's a Medical Device Manufactured by: CID S.p.A. Strada per Crescentino s.n. 13040 Saluggia, Italy.

Not for sale in U.S.A. and Japan.